MICHAEL HOOSIER: Open Payments
NPI 1952850604 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,559 in 86 payments from 15 companies in 2025. Trend: 2023 $634 · 2024 $1,263 · 2025 $2,559
Food & beverage: $2,459Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $464 |
| Janssen Biotech, Inc. | 7 | $347 |
| Incyte Corporation | 11 | $240 |
| Arcutis Biotherapeutics, Inc. | 6 | $238 |
| Botanix SB Inc | 5 | $203 |
| Galderma Laboratories, L.P. | 11 | $199 |
| Lilly USA, LLC | 3 | $157 |
| E.R. Squibb & Sons, L.L.C. | 4 | $155 |
| Novartis Pharmaceuticals Corporation | 5 | $131 |
| PFIZER INC. | 5 | $108 |
Products named: Otezla, TREMFYA, Opzelura, Zoryve, SOFDRA, NEMLUVIO, DUPIXENT, Sotyktu.
Industry payments across CA — which companies pay providers there.
